HemoSense
1 known investors
Abbott Global Point of Care provides portable diagnostic analyzers and testing systems used at the point of care by healthcare professionals, enabling on-site blood chemistry, lipid, and other tests with results that can upload directly to electronic medical records. Its products serve clinical and near-patient testing settings in the in-vitro diagnostics category.
Investors Β· 1
Frequently asked questions
- What does HemoSense do?
- Abbott Global Point of Care provides portable diagnostic analyzers and testing systems used at the point of care by healthcare professionals, enabling on-site blood chemistry, lipid, and other tests with results that can upload directly to electronic medical records. Its products serve clinical and near-patient testing settings in the in-vitro diagnostics category.
- Who are HemoSense's investors?
- HemoSense's investors include New Enterprise Associates (NEA).